TransAct Technologies IncorporatedTACTNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank51
3Y CAGR-37.9%
5Y CAGR-16.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-37.9%/yr
Quarterly compound
5Y CAGR
-16.1%/yr
Recent deceleration
Percentile
P51
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.75% |
| Q3 2025 | -4.00% |
| Q2 2025 | 5.50% |
| Q1 2025 | 4.01% |
| Q4 2024 | -4.15% |
| Q3 2024 | -8.84% |
| Q2 2024 | -8.49% |
| Q1 2024 | -8.94% |
| Q4 2023 | -13.95% |
| Q3 2023 | 0.16% |
| Q2 2023 | 10.40% |
| Q1 2023 | 6.53% |
| Q4 2022 | 7.30% |
| Q3 2022 | -8.61% |
| Q2 2022 | -4.86% |
| Q1 2022 | 14.61% |
| Q4 2021 | 6.18% |
| Q3 2021 | 3.99% |
| Q2 2021 | 0.06% |
| Q1 2021 | 19.72% |
| Q4 2020 | 4.22% |
| Q3 2020 | 5.71% |
| Q2 2020 | -1.30% |
| Q1 2020 | 30.05% |
| Q4 2019 | 1.62% |
| Q3 2019 | -6.01% |
| Q2 2019 | -4.29% |
| Q1 2019 | 9.29% |
| Q4 2018 | -3.62% |
| Q3 2018 | -6.51% |
| Q2 2018 | -3.11% |
| Q1 2018 | 6.82% |
| Q4 2017 | -0.35% |
| Q3 2017 | 12.45% |
| Q2 2017 | 2.72% |
| Q1 2017 | 2.69% |
| Q4 2016 | -14.65% |
| Q3 2016 | 4.04% |
| Q2 2016 | -11.89% |
| Q1 2016 | 11.86% |